Skip to content
Home/Companies/Biotech/Rampart Biosciences

Rampart Biosciences

Biotech·United States·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Rampart Biosciences?

Rampart Biosciences is an American Biotech company, currently owned by HealthCap since 2023.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap VIII · 2021 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More from HealthCap VIII

Other portfolio companies in the same fund.

CurifyLabs
Active
MedTechFinland· 2026
Neobiomics
Active
BiotechSweden· 2026
Gesynta Pharma
Gesynta Pharma
Active
PharmaSweden· 2025
Kivu Bioscience
Active
BiotechUS· 2025
Positrigo
Active
MedTechSwitzerland· 2025
Ariceum Therapeutics
Active
BiotechGermany· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Rampart Biosciences?

Rampart Biosciences is currently owned by HealthCap, through HealthCap VIII, since 2023.

When did HealthCap acquire Rampart Biosciences?

HealthCap acquired Rampart Biosciences in 2023.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue